2 Therefore, to mitigate sequelae, self-monitoring may serve as a useful tool for disease management. Further, ensuring that patients are properly educated is vital when attempting to adequately control their blood glucose or alter drug therapy.3 Epidemiology According to the American Diabetes ...
Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced U.S. Food and Drug Administration (FDA) approval for the Android™ version of its Guardian™ Connect continuous glucose monitoring (CGM) system. DUBLIN, May 22, 2020 (...
Medtronic(NYSE:MDT) said today it won CE Mark approval in the European union for its Guardian Connect mobile continuous glucose monitoring system. The Fridley, Minn.-based medical giant said it is the 1st smartphone-enabled CGM system to win CE Mark approval for the company, and expects to ...
From WebMD: “The continuous glucose monitor is not intended for day-to-day monitoring or long-term self-care, and it is not a replacement for standard blood sugar monitoring. It is only intended for use to discover trends in blood sugar levels. This helps your health care team make the...